Corcept Therapeutics, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc. 1.26%27.0014.1%$158.87m
HZNPHorizon Therapeutics Plc 1.00%78.515.6%$146.71m
ACRSAclaris Therapeutics, Inc. -3.18%17.644.7%$135.97m
BHCBausch Health Cos., Inc. 1.26%27.000.0%$109.48m
CTLTCatalent, Inc. -1.00%115.652.1%$106.75m
JAZZJazz Pharmaceuticals Plc 1.38%170.982.4%$90.98m
AMRNAmarin Corp. Plc 15.42%7.561.5%$62.93m
UTHRUnited Therapeutics Corp. 0.98%169.3514.1%$61.91m
ISRIsoRay, Inc. -1.79%2.202.5%$60.70m
ACSTAcasti Pharma, Inc. -5.25%0.760.2%$57.49m
PRGOPerrigo Co. Plc 2.77%44.496.8%$54.54m
ARGXargenx SE 1.40%315.330.0%$53.36m
SAVACassava Sciences, Inc. 21.83%15.680.0%$52.63m
GWPHGW Pharmaceuticals Plc 1.19%143.396.1%$52.59m
SAGESAGE Therapeutics, Inc. 2.16%90.467.6%$44.58m

Company Profile

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.